(Q35108028)

6 August 2017

1 reference

title

Role of gemcitabine in the treatment of advanced and metastatic breast cancer (English)

1 reference

6 August 2017

Role of Gemcitabine in the Treatment of Advanced and Metastatic Breast Cancer (English)

1 reference

24 December 2023

main subject

metastatic breast cancer

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12697958

reference URL

24 December 2023

1 reference

24 December 2023

author name string

Volker Heinemann

1

1 reference

6 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12697958

reference URL

24 December 2023

publication date

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

64

1 reference

6 August 2017

191-206

1 reference

6 August 2017

3

1 reference

Gemcitabine: a pharmacologic and clinical overview

6 August 2017

1

1 reference

Gemcitabine as first-line therapy in patients with metastatic breast cancer: a phase II trial

24 December 2023

2

1 reference

Single-agent gemcitabine is active in previously treated metastatic breast cancer

24 December 2023

3

1 reference

Phase II study of weekly gemcitabine in patients with metastatic breast cancer relapsing or failing both an anthracycline and a taxane

24 December 2023

4

1 reference

Results and long term follow-up for 1581 patients with metastatic breast carcinoma treated with standard dose doxorubicin-containing chemotherapy: a reference

24 December 2023

5

1 reference

Gemcitabine plus dose-escalated epirubicin in advanced breast cancer: results of a phase I study

24 December 2023

6

1 reference

Drug distribution and pharmacokinetic/pharmacodynamic relationship of paclitaxel and gemcitabine in patients with non-small-cell lung cancer

24 December 2023

7

1 reference

Monthly docetaxel and weekly gemcitabine in metastatic breast cancer: a phase II trial

24 December 2023

8

1 reference

Phase II trial of the use of paclitaxel and gemcitabine as a salvage treatment in metastatic breast cancer

24 December 2023

9

1 reference

Vinorelbine--a clinical review

24 December 2023

10

1 reference

Treatment of advanced breast cancer with gemcitabine and vinorelbine plus human granulocyte colony-stimulating factor

24 December 2023

11

1 reference

Gemcitabine and vinorelbine in pretreated advanced breast cancer: a pilot study

24 December 2023

12

1 reference

Phase II trial of biweekly administration of vinorelbine and gemcitabine in pretreated advanced breast cancer

24 December 2023

13

1 reference

Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer progressing after first-line taxane-based chemotherapy: a phase II study conducted by the Hellenic Cooperative Oncology Group

24 December 2023

14

1 reference

Phase I/II study of gemcitabine in association with vinorelbine for metastatic breast cancer.

24 December 2023

15

1 reference

Gemcitabine plus epirubicin plus taxol (GET) in advanced breast cancer: a phase II study

24 December 2023

16

1 reference

Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.

24 December 2023

17

1 reference

24 December 2023

Identifiers

DOI

10.1159/000069315

1 reference

6 August 2017

1 reference